AOD-9604
Other ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
Synthetic fragment of human growth hormone marketed for fat-loss claims. FDA flags limited safety information, immunogenicity/impurity concerns, and serious adverse event signals with unclear causality.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This safety record covers a controlled, investigational, or otherwise out-of-scope substance. It remains available for reference, but it is not part of NutriStack's public supplement publication set.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
AOD-9604 is an other most often used for no approved wellness use, human efficacy evidence is insufficient for consumer guidance, reference-only safety profile. NutriStack rates the overall evidence as insufficient. A typical adult dose is Not provided; NutriStack does not provide dosing guidance for research peptides., commonly taken as not supported for human use outside approved clinical research or regulated medical care. This profile indexes 3 sources.
- Unknown product purity, potency, and sterility risk outside regulated drug supply
- Injection-site reactions or infection risk with injectable products
- Immune reactions are possible with peptide impurities or aggregation
- Pregnancy or nursing
- History of cancer or active malignancy unless specifically cleared by an oncologist
The bottom line
Evidence rating insufficient. Most-documented uses: no approved wellness use, human efficacy evidence is insufficient for consumer guidance, reference-only safety profile. 3 sources indexed (2004–2026), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Derived from the lipolytic region of human growth hormone and investigated for lipid metabolism, but human clinical efficacy and long-term safety are not established for consumer use.
Dosing & protocol.
Route-specific guidance is intentionally not provided for unapproved research peptides.
Full safety detail.
Side effects
- Unknown product purity, potency, and sterility risk outside regulated drug supply
- Injection-site reactions or infection risk with injectable products
- Immune reactions are possible with peptide impurities or aggregation
Contraindications
- Pregnancy or nursing
- History of cancer or active malignancy unless specifically cleared by an oncologist
- Use by competitive athletes subject to anti-doping rules
- Use without clinician supervision
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Reviews & position papers
1- 1AOD-9604 MetabolicSource linkedPMIDWilding J · Curr Opin Investig Drugs · 2004
Investigational-drug review; not evidence of approved consumer efficacy.
Mechanistic & preclinical
1- 2Detection and in vitro metabolism of AOD9604Source linkedPMIDCox HD et al. · Drug Test Anal · 2015
Analytical detection/metabolism study; does not establish clinical safety or efficacy.
Reference material
1- 3Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety RisksSource linkedURLU.S. Food and Drug Administration · FDA · 2026
FDA flags significant immunogenicity risk, peptide impurity/API characterization concerns, limited safety information, and serious adverse event signals with unclear causality.
Common questions.
Quick answers about AOD-9604, drawn from the data on this page.
What is AOD-9604?
Synthetic fragment of human growth hormone marketed for fat-loss claims. FDA flags limited safety information, immunogenicity/impurity concerns, and serious adverse event signals with unclear causality.
What is AOD-9604 used for?
Commonly cited benefits of AOD-9604 include: No approved wellness use; Human efficacy evidence is insufficient for consumer guidance; Reference-only safety profile. NutriStack rates the overall evidence as insufficient.
What is a typical dose of AOD-9604?
A typical adult dose of AOD-9604 is Not provided; NutriStack does not provide dosing guidance for research peptides.. The commonly recommended form is Not supported for human use outside approved clinical research or regulated medical care. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of AOD-9604?
Reported side effects include unknown product purity, potency, and sterility risk outside regulated drug supply, injection-site reactions or infection risk with injectable products, immune reactions are possible with peptide impurities or aggregation. This is educational information; check with a healthcare professional before use.
How strong is the evidence for AOD-9604?
NutriStack rates this as Insufficient, meaning the body of evidence reviewed in NutriStack's tiering framework. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
AOD-9604 in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.